Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ

7. S. К. Park et al., “Association between Serum Ferritin Levels and the Incidence of Obesity in Korean Men: A Prospective Cohort Study,” Endocrine Journal, 61, no. 3 (2014): 215-24, DOI: 10.1507/endocrj.EJ13-0173.

8. Там же.

9. J. M. Fernandez-Real et al., “Serum Ferritin as a Component of the Insulin Resistance Syndrome,” Diabetes Care, 21, no. 1 (1998): 62–68, DOI: 10.2337/dia-care.21.1.62.

10. }. Montonen et al., “Body Iron Stores and Risk of Type 2 Diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study,” Diabetologia, 55, no. 10 (2012): 2613-21, DOI: 10.1007/s00125-012-2633-y.

11. J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart, “Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion,” Clinical Chemistry, 51, no. 7 (June 2005): 1201-5, DOI: 10.1373/clinchem.2004.046847.

12. B. J. Van Lenten et al., “Lipid-Induced Changes in Intracellular Iron Homeostasis in Vitro and in Vivo,” Journal of Clinical Investigation, 95, no. 5 (1995): 2104-10, DOI: 10.1172/JCI117898.

13. N. Stadler, R. A. Lindner, and M. J. Davies, “Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper,” Arteriosclerosis, Thrombosis, and Vascular Biology, 24 (2004): 949-54, DOI: 10.1161/01. ATV.0000124892.90999.cb.

14. W. B. Kannel et al., “Menopause and Risk of Cardiovascular Disease: The Framingham Study,” Annals of Internal Medicine, 85 (1976): 447-52, DOI: 10.7326/0003-4819-85-4-447.

15. M. A. Lovell et al., “Copper, Iron and Zinc in Alzheimer’s Disease Senile Plaques,” Journal of the Neurological Sciences, 158, no. 1 (June 11, 1998): 47–52, DOI: 10.1016/S0022-510X(98)00092-6.

16. K. Jellinger et al., “Brain Iron and Ferritin in Parkinsons and Alzheimer’s diseases,” Journal of Neural Transmission, 2 (1990): 327, DOI: 10.1007/BF02252926.

17. G. Bartzokis et al., “Brain Ferritin Iron as a Risk Factor for Age at Onset in Neuro-degenerative Diseases,” Annals of the New York Academy of Sciences, 1012,(2004): 224-36, DOI: 10.1196/annals.l306.019.

18. S. Ayton et al., “Ferritin Levels in the Cerebrospinal Fluid Predict Alzheimer’s Disease Outcomes and Are Regulated by APOE,” Nature Communications, 6 (2015): 6760, DOI: 10.1038/ncomms7760.

19. W. Z. Zhu et al., “Quantitative MR Phase-Corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer’s Disease,” Radiology, 253 (2009): 497–504, DOI: 10.1148/radiol.2532082324.

20. A. A. Alkhateeb and J. R. Connor, “The Significance of Ferritin in Cancer: Anti-Oxidation, Inflammation and Tumorigenesis,” Biochimica et Biophysica Acta, 1836, no. 2 (Dec 2013):245-54, DOI: 10.1016/j.bbcan.2013.07.002.

21. J. I. Wurzelmann et al, “Iron Intake and the Risk of Colorectal Cancer,” Cancer Epidemiology, Biomarkers and Prevention, 5, no. 7 (July 1, 1996): 503-7. PMID: 8827353.

22. Y. Deugnier, “Iron and Liver Cancer,” Alcohol, 30, no. 2 (2003): 145-50.

23. L. R. Zacharski et al, “Decreased Cancer Risk after Iron Reduction in Patients with Peripheral Arterial Disease: Results from a Randomized Trial,” JNCI: Journal of National Cancer Institute, 100, no. 14 (2008): 996-1002, DOI: 10.1093/jnci/ djn209.

24. L. Valenti et al., “Association between Iron Overload and Osteoporosis in Patients with Hereditary Hemochromatosis,” Osteoporosis International, 20, no. 4 (April, 2009): 549-55, DOI: 10.1007/s00198-008-0701-4.

25. “Hemochromatosis,” National Institute of Diabetes and Digestive and Kidney Disease (2016), http://www.niddk.nih.gov/health-information/health-top-ics/liver-disease/hemochromatosis/Pages/facts.aspx, accessed May 9, 2016.

26. “Welcome,” Iron Disorders Institute (2016) http://www.hemochromatosis. org/#symptoms, accessed May 9, 2016.

27. “Serum Iron Test,” MedlinePlus Medical Encyclopedia (2016), https://www.nlm. nih.gov/medlineplus/ency/article/003488.htm, accessed May 9, 2016.

28. “TIBC, UIBC, and Transferrin Test: Iron Binding Capacity; IBC; Serum Iron-Binding Capacity; Siderophilin; Total Iron Binding Capacity; Unsaturated Iron Binding Capacity,” Lab Tests Online (2016), https://lab-testsonline.org/understanding/analytes/tibc/tab/test/, accessed May 9, 2016.

29. L. Zacharski, “Ferrotoxic Disease: The Next Great Public Health Challenge,” Clinical Chemistry, 60, no. 11 (November 2014): 1362-4, DOI: 10.1373/ clinchem.2014.231266.